Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL2916898 | 0.96 | — | — | |
| Glycine SCHEMBL19100314 | 0.96 | GLRA1 (0.91) | — | |
| Glycine SCHEMBL2163124 | 0.92 | — | — | |
| Glycine SCHEMBL3941231 | 0.92 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL4850247 | 0.92 | — | — | |
| Glycine SCHEMBL3145399 | 0.92 | — | — | |
| Glycine SCHEMBL7499558 | 0.92 | — | — | |
| Glycine SCHEMBL5943684 | 0.92 | — | — | |
| Glycine SCHEMBL3689465 | 0.92 | — | — | |
| Glycine SCHEMBL2509755 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7601685-B2 | Comprises fusion proteins for use in microarray designed for tissue repair, regeneration and/or remodeling and/or drug delivery | EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) | 2009-10-13 | — | — | US | disclosed |
| US-20030187232-A1 | Growth factor modified protein matrices for tissue engineering | EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH UNIVERSITAT ZURICH | 2003-10-02 | — | — | US | disclosed |